Srinagar, November 29, 2024: Indraprastha Apollo Hospitals organized a pioneering medical conference in Srinagar, focusing on two crucial and often complex areas of healthcare—fetal medicine and the management of breast cancer during pregnancy. The event brought together leading medical experts to share their insights on these critical subjects. Notable speakers included Dr. Anita Kaul, Clinical Director & Consultant in Fetal Medicine and Genetics at the Apollo Centre for Fetal Medicine and Therapy and Dr. Sameer Kaul, Senior Consultant in Surgical & Clinical Oncology at Apollo Cancer Institutes
The conference aimed to raise awareness and discuss best practices for managing unique fetal challenges. Dr. Anita Kaul spoke on day to day challenges in fetal medicine highlighting the intricacies of diagnosing and managing fetal anomalies, the advances in genetic diagnosis, and intrauterine fetal surgical procedures, while Dr. Sameer Kaul addressed complexities of managing cancer in expectant mothers. He explored the latest approaches to ensuring safe and effective cancer treatment during pregnancy, emphasizing the importance of early diagnosis and multidisciplinary care to protect the health of both mother and fetus.
The conference provided a platform to gain insights from leading specialists. Discussions emphasized the importance of collaboration, early diagnosis, and multidisciplinary care in addressing the complex challenges faced by pregnant women with high-risk pregnancies and breast cancer.
Dr. Anita Kaul, Clinical Director & Consultant in Fetal Medicine and Genetics at the Apollo Centre for Fetal Medicine, said, “Fetal medicine is a rapidly evolving field that presents many challenges, particularly when it comes to diagnosing and managing fetal anomalies and genetic disorders. The complexity of high-risk pregnancies requires a comprehensive approach, integrating advanced imaging and lab diagnostic tools with close teamwork with the obstetrician and neonatologists to ensure the best possible outcomes. Our goal is to equip healthcare professionals with the knowledge and strategies to navigate these challenges, providing expectant mothers with the best care for both themselves and their babies.”
Dr. Sameer Kaul, Senior Consultant in Surgical & Clinical Oncology at Apollo Cancer Institutes, said, “Managing cancer during pregnancy is a delicate and complex issue, requiring a careful balance between treating the mother’s cancer while safeguarding the health of the fetus. Early diagnosis and a multidisciplinary approach are key to ensuring safe and effective treatment. This conference serves as an invaluable platform to share the latest advancements in the field and reinforce the importance of tailored care plans that prioritize both the mother’s and child’s health throughout the pregnancy. By fostering collaboration, we can continue to improve outcomes for expectant mothers with breast cancer.”
About Indraprastha Apollo Hospitals:
Indraprastha Apollo Hospitals, India’s first JCI accredited hospital, is a joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited. Commissioned in July 1996, it is the third super-specialty tertiary care hospital set up by the Apollo Hospitals Group. Spread over 15 acres, it houses 57 specialties with more than 300 specialists and more than 700 operational beds, 19 operation theatres, 138 ICU beds, round-the-clock pharmacy, NABL accredited laboratories, 24-hour emergency services and an active air ambulance service. Apollo Hospitals Delhi has the leading programme in kidney and liver transplant in the country. The first successful paediatrics and adult liver transplants in India were performed at Indraprastha Apollo Hospitals. The hospital is at the forefront of medical technology and expertise. It provides a complete range of latest diagnostic, medical and surgical facilities for the care of its patients. The Hospital has introduced the most sophisticated imaging technology to India with the introduction of 64 slice CT and 3 Tesla MRI, Novalis Tx and the integrated PET Suite.
In a groundbreaking advancement, Indraprastha Apollo Hospitals has recently introduced the ZAP-X Gyroscopic Radiosurgery Platform, revolutionizing brain tumor treatment across South Asia. This state-of-the-art technology offers a non-invasive altessrnative to traditional brain surgery, promising improved patient outcomes and comfort. Backed by the experience and expertise of Radiation Oncologists and technical team, Indraprastha Apollo also brings the revolutionary RADIXACT – X9 that combines imaging and treatment delivery to precisely target a wide variety of Cancers.
Indraprastha Apollo has pioneered the concept of preventive health check programmes and has created a satisfied customer base over decades. The Hospital has been consistently ranked amongst the best 10 hospitals in India by The Week survey for the past few years.
